Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
An overview of where to locate stock index listings worldwide, with guidance on finding the right benchmarks for your analysis.
17,106 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
FuelCell Energy leads a sell-off in fuel-cell stocks as investors lock in gains after a sharp rally, while Bloom Ener...
When a rocket-ride valuation grabs headlines, it’s easy to chase the hype. This guide breaks down spacex's market qui...
Palantir has won a landmark Army data overhaul deal worth $10 billion, signaling a decade-long shift in defense IT an...
June delivered a sharp tilt in energy markets as crude prices slid. This article breaks down why prices swooned june....
SpaceX announces a year-long insider lockup with a 15-date unlock schedule to follow. The move tests liquidity expect...
KBW argues United Wholesale Mortgage could emerge stronger after failing to win Two Harbors, with faster debt reducti...
For dividend kings long-term investors, a disciplined, income-forward approach can power wealth over two decades. Thi...
In 2026, two very different healthcare players—Abbott Laboratories and Glaukos—offer contrasting paths to potential g...
Micron’s blowout quarter ignited a rally that dwarfed many peers, but the broader memory-chip sector lifted a key ETF...
Analysts see value in Nvidia-backed AI infrastructure bets after last week’s pullback, highlighting dip-buy opportuni...
CleanSpark stock surged after disclosing a $6.6 billion, 20-year data center lease in Georgia, underscoring a shift f...